Skip to content
Screener

Apogee Therapeutics, Inc. APGE Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.31B
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$11.24M+108%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$256K0.0%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$2.02M+6.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$59M-14.5%

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$10.17B+380%
Enterprise value$9.73B+385%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:20 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-215698
Line itemMARCH 31,2026DECEMBER 31,2025
Long-term marketable securities198,354172,730
Property and equipment, net5,2805,688
Right-of-use asset, net7,7078,687
Other non-current assets8,5168,671
Total assets$1,293,654$937,134
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$1,237$1,221

Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)

FAQ

What is Apogee Therapeutics, Inc.'s other non-current assets?
Apogee Therapeutics, Inc. (APGE) reported other non-current assets of $8.52M in Q1 2026.
How has Apogee Therapeutics, Inc.'s other non-current assets changed year-over-year?
Apogee Therapeutics, Inc.'s other non-current assets increased by 16.0% year-over-year, from $7.34M to $8.52M.
What is the long-term trend for Apogee Therapeutics, Inc.'s other non-current assets?
Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s other non-current assets has grown at a 365.0% compound annual growth rate (CAGR), from $401K to $8.67M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Apogee Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude